According to IQVIA MAT July 2025 data, Rivaroxaban for Oral Suspension, 1 mg/mL (RLD Xarelto) had estimated annual sales of ...

The orodispersible film formulation offers new dosing options for preventing clots and treating thrombotic events across ...

Shares of a company manufacturing niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service, hit a 5 percent upper circuit, after EMA granted initial ...

Rate-sensitive sectors such as banking, financial services, auto, and realty are likely to remain in focus today. While the ...

Over the last five years, the industry has traded as high as 20.80X, as low as 12.92X and at a median of ... making up for the decline in sales of oral anticoagulant Xarelto. Bayer is also working to ...

According to the company filing, CarWale and BikeWale saw their highest-ever single-day traffic on Monday. Traffic reached an all-time high, increasing by 74% from the first day of Navratri the ...

From patent cliffs and government price controls, to self-pay models and staff-model HMOs, a look at the forces that could ...

1 School of Clinical, Shandong Second Medical University, Weifang, Shandong, China 2 Weifang People's Hospital, Weifang, Shandong, Department of Vascular Surgery, Weifang, Shandong, China Lower ...

Rivaroxaban for oral suspension, 1 mg/ml (RLD Xarelto) had a market value of roughly $11 million, per IQVIA July 2025 data.

Lupin has introduced Rivaroxaban for Oral Suspension in the US market, offering a generic version of Xarelto. This medication ...

The product is a generic version of Xarelto for Oral Suspension, 1 mg/mL, originally developed by Janssen Pharmaceuticals, ...

Even though American TV shows tend to get the lion’s share of coverage and attention, Canada shouldn't be left out of any discussion of great TV. The United States’ northern neighbor is remarkably ...